Early improvement in SHIM scores with Revactin^®

Int J Impot Res. 2020 Mar;32(2):255-256. doi: 10.1038/s41443-019-0123-1. Epub 2019 Jan 31.

Authors

Sabine Nguyen¹, Magda Shaheen^{2

3}, Youngju Pak⁴, Jacob Rajfer⁵

Affiliations

¹ Department of Health and Life Sciences, Charles R. Drew University of Medicine and Science, Los Angeles, CA, USA.
² Department of Surgery, College of Medicine, Charles R Drew University, Los Angeles, CA, USA.
³ David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
⁴ LA Biomed Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.
⁵ Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. jrajfer@ucla.edu.

PMID: 30705436
DOI: 10.1038/s41443-019-0123-1

No abstract available

Publication types

Letter

MeSH terms

Adult
Erectile Dysfunction / drug therapy*
Humans
Male
Middle Aged
Treatment Outcome
Urological Agents / therapeutic use*

Substances

Urological Agents